权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

NCTN Deep South Research Consortium

NCTN 深南研究联盟

基本信息

批准号：
9236167
负责人：
MARY-ANN BJORNSTI
金额：
$ 49.78万
依托单位：
UNIVERSITY OF ALABAMA AT BIRMINGHAM
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-04-16 至 2019-02-28
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/9236167
关键词：
Achievement Address Alabama American College of Radiology Imaging Network Area Arkansas Basic Science Cancer Biology Cancer Control Cancer Patient Cancer and Leukemia Group B Clinical Investigator Clinical Research Clinical Trials Clinical Trials Cooperative Group Communities Community Outreach Comprehensive Cancer Center Country Deep South Detection Diagnosis Doctor of Medicine Eastern Cooperative Oncology Group Eligibility Determination Ensure Faculty Fostering Funding Gynecologic Oncology Group Home environment Hospitals Institution Intention International Investigational Therapies Knowledge Lead Leadership Louisiana Malignant Neoplasms Malignant neoplasm of brain Malignant neoplasm of cervix uteri Malignant neoplasm of ovary Malignant neoplasm of pancreas Mentors Minority Minority Participation Mississippi Names National Clinical Trials Network National Surgical Adjuvant Breast and Bowel Project Newly Diagnosed Outcome Participant Patients Phase Physicians Principal Investigator Process Quality of life Radiation Therapy Oncology Group Recording of previous events Recruitment Activity Reproduction spores Research Research Infrastructure Research Personnel Research Training Scientist Site Socioeconomic Status Southwest Oncology Group Training Training Programs Training and Infrastructure Translating Translational Research Universities Vision Work anticancer research cancer care cancer clinical trial cancer health disparity cancer prevention cancer risk demographics ethnic minority population health disparity interest malignant breast neoplasm member minority health minority scientist next generation organizational structure patient population population based programs public health relevance racial health disparity survivorship translational scientist

项目摘要

DESCRIPTION (provided by applicant): The University of Alabama at Birmingham (UAB) Comprehensive Cancer Center (CCC) has a long history of participation within the nation's cancer related Clinical Trials Cooperative Group Program. Specifically, UAB was a founding member of the GOG, and has been a member of RTOG, ECOG, ACRIN. CALGB, NSABP, and SWOG. The UAB CCC now submits this proposal to become a Lead Academic Participating Site, specifically named the NCTN Deep South Research Consortium, in the NCI's newly restructured National Clinical Trials Network (NCTN) Program. It is our intention to continue as a leading contributor of scientific leaders and clinical trial participants to the NCTN Program in th U.S. and particularly in the Southeast. To accomplish this overall vision, we propose the following specific aims: 1) To further enhance the involvement of existing UAB CCC scientific leadership in NCTN Center related clinical and translational research and to develop the next generation of NCTN Center scientific leaders within the UAB CCC, and 2) To further refine a clinical trials process within the UAB CCC that optimizes accrual of potentially eligible cancer patients and patients at risk for cancer to NCTN Center clinical trials. We include in this proposa a detailed description of our NCI cooperative group scientific and patient accrual contributions and accomplishments, a leadership and organizational structure for our proposed Consortium, and how we intend to utilize existing UAB CCC infrastructure to achieve our aims. We also include a detailed description of our proposed Junior Investigator Recruitment and Mentoring Program.

描述（由申请人提供）：阿拉巴马大学伯明翰分校 (UAB) 综合癌症中心 (CCC) 长期以来一直参与国家癌症相关临床试验合作组计划。具体来说，UAB是GOG的创始成员，并且一直是RTOG、ECOG、ACRIN的成员。 CALGB、NSABP 和 SWOG。 UAB CCC 现在提交了成为 NCI 新重组的国家临床试验网络 (NCTN) 计划中的主要学术参与站点的提案，具体名称为 NCTN 深南研究联盟。我们打算继续作为美国尤其是东南部 NCTN 计划的科学领导者和临床试验参与者的主要贡献者。为了实现这一总体愿景，我们提出以下具体目标：1) 进一步加强现有 UAB CCC 科学领导力对 NCTN 中心相关临床和转化研究的参与，并在 UAB CCC 内培养下一代 NCTN 中心科学领导者，以及 2) 进一步完善 UAB CCC 内的临床试验流程，以优化潜在合格癌症患者和有癌症风险的患者参加 NCTN 中心临床试验的机会。我们在此提案中详细描述了我们的 NCI 合作小组的科学和患者应计贡献和成就、我们提议的联盟的领导和组织结构，以及我们打算如何利用现有的 UAB CCC 基础设施来实现我们的目标。我们还详细描述了我们拟议的初级研究员招募和指导计划。